Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.73 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | HCAR1 | Q9BXC0 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | PDE7A | Q13946 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | HPD | P32754 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30726101 | 1.00 | ALDH1A1 (0.73) | ALDH1A1L3MBTL1LMNATSHRGLA | |
| SCHEMBL123247 | 0.90 | ALDH1A1 (0.68) | ALDH1A1L3MBTL1LMNATSHRGLA | |
| Methaqualone SCHEMBL43892 | 0.84 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1LMNATSHRGLA | |
| Methaqualone SCHEMBL29386732 | 0.84 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1LMNATSHRGLA | |
| Methaqualone SCHEMBL20471677 | 0.84 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1LMNATSHRGLA | |
| Methaqualone SCHEMBL29355239 | 0.84 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1LMNATSHRGLA | |
| SCHEMBL6601150 | 0.84 | L3MBTL1 (0.62) | ALDH1A1L3MBTL1LMNAGLAHCAR1 | |
| SCHEMBL16596956 | 0.83 | L3MBTL1 (0.77) | ALDH1A1L3MBTL1LMNATSHRGLA | |
| Methaqualone SCHEMBL3500629 | 0.83 | ALDH1A1 (0.97) | ALDH1A1L3MBTL1LMNATSHRGLA | |
| Methaqualone SCHEMBL29849847 | 0.83 | ALDH1A1 (0.97) | ALDH1A1L3MBTL1LMNATSHRGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020006606-A1 | A PHARMACEUTICAL COMPOSITION AND METHOD OF USE OF SAME | HELIUM 3 RESOURCES PTY LTD (AU) | 2020-01-09 | — | — | WO | claimed |
| US-20120095104-A1 | USE OF VASOCONSTRICTORS | ZACHAR ORON (IL) | 2012-04-19 | — | — | US | claimed |
| EP-2376073-A2 | DERMAL APPLICATION OF VASOCONSTRICTORS | Zachar, Oron (IL) | 2011-10-19 | — | — | EP | claimed |
| US-20110144209-A1 | USE OF VASOCONSTRICTORS | ZACHAR ORON | 2011-06-16 | — | — | US | claimed |
| EP-2313037-A1 | DERMAL APPLICATION OF VASOCONSTRICTORS | Zachar, Oron (IL) | 2011-04-27 | — | — | EP | claimed |
| WO-2010063030-A2 | DERMAL APPLICATION OF VASOCONSTRICTORS | FEIGELSON, DANIEL (IL) | 2010-06-03 | — | — | WO | claimed |
| WO-2010001391-A1 | DERMAL APPLICATION OF VASOCONSTRICTORS | ZACHAR ORON (IL) | 2010-01-07 | — | — | WO | claimed |
| US-20250367232-A1 | HALOGEN TREATMENT OF HEART ATTACK AND ISCHEMIC INJURY | HUTCHINSON FRED CANCER RES (US) | 2025-12-04 | — | — | US | disclosed |
| US-20250255928-A1 | USE OF COLLAGEN HYDROLYSATE AS AN ACTIVE INGREDIENT IN AMELIORATING SLEEP | ROUSSELOT B.V. (BE) | 2025-08-14 | — | — | US | disclosed |
| US-12377235-B2 | Multipurpose device | INSTITUTE FOR CANCER RESEARCH (US) | 2025-08-05 | — | — | US | disclosed |
| EP-4463177-B1 | USE OF COLLAGEN HYDROLYSATE AS AN ACTIVE INGREDIENT IN AMELIORATING SLEEP | ROUSSELOT BV (BE) | 2025-05-14 | — | — | EP | disclosed |
| US-20250032419-A1 | SOLID PHARMACEUTICAL COMPOSITIONS AND METHODS OF PRODUCING THE SAME | GALVITA AG (CH) | 2025-01-30 | — | — | US | disclosed |
| EP-4463177-A1 | USE OF COLLAGEN HYDROLYSATE AS AN ACTIVE INGREDIENT IN AMELIORATING SLEEP | Rousselot BV (BE) | 2024-11-20 | — | — | EP | disclosed |
| US-20120095104-A1 | USE OF VASOCONSTRICTORS | ZACHAR ORON (IL) | 2012-04-19 | — | — | US | disclosed |
| CN-102300566-A | Cutaneous application of vasoconstrictors | — | 2011-12-28 | — | — | CN | disclosed |
| EP-2376073-A2 | DERMAL APPLICATION OF VASOCONSTRICTORS | Zachar, Oron (IL) | 2011-10-19 | — | — | EP | disclosed |
| US-20110144209-A1 | USE OF VASOCONSTRICTORS | ZACHAR ORON | 2011-06-16 | — | — | US | disclosed |
| EP-2313037-A1 | DERMAL APPLICATION OF VASOCONSTRICTORS | Zachar, Oron (IL) | 2011-04-27 | — | — | EP | disclosed |
| WO-2010063030-A2 | DERMAL APPLICATION OF VASOCONSTRICTORS | FEIGELSON, DANIEL (IL) | 2010-06-03 | — | — | WO | disclosed |
| WO-2010001391-A1 | DERMAL APPLICATION OF VASOCONSTRICTORS | ZACHAR ORON (IL) | 2010-01-07 | — | — | WO | disclosed |